Iovance Biotherapeutics Inc (IOVA)

Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in Iovance Bioth - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Iovance Biotherapeutics director Maynard sells $503k in stock - Investing.com

Nov 14, 2024

Nov 14, 2024

IOVA (Iovance Biotherapeutics) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 13, 2024

Nov 13, 2024

Iovance Biotherapeutics' SWOT analysis: stock shows promise amid challenges By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 12, 2024

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Purchased by Principal Financial Group Inc. - MarketBeat

Nov 12, 2024

Nov 11, 2024

Iovance Biotherapeutics Q3: A Beat, But A SelloffNow A Buy Opportunity - Seeking Alpha

Nov 11, 2024

Nov 11, 2024

HC Wainwright Has Positive Outlook for IOVA FY2027 Earnings - MarketBeat

Nov 11, 2024

Nov 09, 2024

Earnings call: Iovance reported a third-quarter product revenue of $58.6 million - Investing.com India

Nov 09, 2024

Nov 09, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance UK

Nov 09, 2024

Nov 09, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 08, 2024

IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line - MSN

Nov 08, 2024

Nov 08, 2024

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap DownTime to Sell? - MarketBeat

Nov 08, 2024

Nov 08, 2024

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlig - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ... - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Q3 Earnings Estimate for IOVA Issued By HC Wainwright - MarketBeat

Nov 08, 2024

Nov 08, 2024

Iovance Biotherapeutics’ Strong Q3 2024 Performance - TipRanks

Nov 08, 2024

Nov 07, 2024

Iovance falls 12% despite Q3 beats; reaffirms 2024 revenue guidance - MSN

Nov 07, 2024

Nov 07, 2024

Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Iovance Biotherapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 07, 2024

Nov 07, 2024

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Iovance Biotherapeutics earnings beat by $0.02, revenue topped estimates - Investing.com UK

Nov 07, 2024

Nov 07, 2024

Iovance Q3 Revenue Surges to $58.6M as Amtagvi Launch Gains Momentum | IOVA Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

A Peek at Iovance Biotherapeutics's Future Earnings - Benzinga

Nov 06, 2024

Nov 06, 2024

HC Wainwright Reaffirms Buy Rating for Iovance Biotherapeutics (NASDAQ:IOVA) - MarketBeat

Nov 06, 2024

Nov 05, 2024

Iovance Biotherapeutics Options Trading: A Deep Dive into Market Sentiment - Benzinga

Nov 05, 2024

Nov 01, 2024

Iovance Biotherapeutics (IOVA) Set to Announce Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024 - The Manila Times

Oct 31, 2024

Oct 31, 2024

Iovance Biotherapeutics to Host Third Quarter and - GlobeNewswire

Oct 31, 2024

Oct 26, 2024

(IOVA) Trading Report - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

Is Iovance Biotherapeutics Stock a Buy Now? - MSN

Oct 25, 2024

Oct 24, 2024

Why Iovance Biotherapeutics (IOVA) Stock is Moving Today - GuruFocus.com

Oct 24, 2024

Oct 24, 2024

Why Iovance Biotherapeutics Stock Triumphed on Thursday - MSN

Oct 24, 2024

Oct 24, 2024

Iovance Biotherapeutics (NASDAQ:IOVA) Trading Up 6.5%Time to Buy? - MarketBeat

Oct 24, 2024

Oct 24, 2024

Smart Money Is Betting Big In IOVA Options - Benzinga

Oct 24, 2024

Oct 24, 2024

Iovance Biotherapeutics (NASDAQ:IOVA) Now Covered by Analysts at UBS Group - MarketBeat

Oct 24, 2024

Oct 19, 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 19, 2024

Oct 18, 2024

Investors Purchase High Volume of Iovance Biotherapeutics Call Options (NASDAQ:IOVA) - MarketBeat

Oct 18, 2024

Oct 18, 2024

State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc - Yahoo Finance

Oct 18, 2024

Oct 18, 2024

First Week of October 18th Options Trading For Iovance Biotherapeutics - Nasdaq

Oct 18, 2024

Oct 17, 2024

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Up 5.7%Should You Buy? - MarketBeat

Oct 17, 2024

Oct 16, 2024

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts? - Insider Monkey

Oct 16, 2024

Oct 15, 2024

8 Most Promising Stocks to Buy According to Wall Street Analysts - Insider Monkey

Oct 15, 2024

Oct 14, 2024

Tumor Infiltrating Lymphocyte (TIL) Market Development Status 2034 |Iovance Biotherapeutics, Optera Therapeutics Corp, T – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024

Oct 12, 2024

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy? - Insider Monkey

Oct 12, 2024

Oct 11, 2024

Iovance Biotherapeutics (FRA:2LB) Debt-to-EBITDA : -0.22 (As of Jun. 2024) - GuruFocus.com

Oct 11, 2024

Oct 10, 2024

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Stock Under $10 With High Potential? - Insider Monkey

Oct 10, 2024